{
    "clinical_study": {
        "@rank": "131272", 
        "arm_group": [
            {
                "arm_group_label": "High dose caffeine", 
                "arm_group_type": "Active Comparator", 
                "description": "High dose (loading 40 mg/kg/day equivalent to 20 mg /kg/day of caffeine base and maintenance of 20 mg/kg/day equivalent to 10 mg /kg/day of caffeine base)"
            }, 
            {
                "arm_group_label": "Low dose caffeine", 
                "arm_group_type": "Active Comparator", 
                "description": "Low dose (loading 20 mg/kg/day equivalent to 10 mg /kg/day of caffeine base and maintenance of 10 mg/kg/day equivalent to 5 mg /kg/day of caffeine base) caffeine."
            }
        ], 
        "brief_summary": {
            "textblock": "The optimum caffeine dose for apnea of prematurity has not been well investigated so the\n      objective of the study is to compare high versus low dose of caffeine citrate to facilitate\n      successful extubation in mechanically ventilated preterm infants."
        }, 
        "brief_title": "High Versus Low Dose of Caffeine for Apnea of Prematurity", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Apnea", 
            "Preterm Infants"
        ], 
        "condition_browse": {
            "mesh_term": "Apnea"
        }, 
        "detailed_description": {
            "textblock": "A randomized, double blind, clinical trial which will be conducted in Neonatal Intensive\n      Care Unit, Mansoura University Children Hospital, Egypt on preterm infants born less than 32\n      weeks gestation mechanically ventilated within the first 10 days of life to study the\n      optimum caffeine dose for apnea of prematurity and compare High dose (loading 40 mg/kg/day\n      equivalent to 20 mg /kg/day of caffeine base and maintenance of 20 mg/kg/day equivalent to\n      10 mg /kg/day of caffeine base) versus low dose (loading 20 mg/kg/day equivalent to 10 mg\n      /kg/day of caffeine base and maintenance of 10 mg/kg/day equivalent to 5 mg /kg/day of\n      caffeine base) caffeine citrate started within the first 10 days of life and its effect on\n      need of re-intubation within 72 hours of extubation from mechanical ventilation as primary\n      outcome and frequency and duration of apnea, duration of mechanical ventilation and oxygen\n      support, length of hospital stay, neonatal mortality, chronic lung disease, necrotising\n      enterocolitis, intraventricular haemorrhage, periventricular leukomalacia, hydrocephalus,\n      retinopathy of prematurity, and caffeine side effects as secondary outcomes."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  newborn infant less than 32 weeks gestation with the diagnosis of apnea\n\n        Exclusion Criteria:\n\n          -  newborn infants with gestational age more than 32 weeks.\n\n          -  newborn infant with congenital malformations or chromosomal anomalies."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "10 Days", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 27, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02103777", 
            "org_study_id": "NICU MUCH 2013"
        }, 
        "intervention": {
            "arm_group_label": [
                "High dose caffeine", 
                "Low dose caffeine"
            ], 
            "description": "Caffeine will be given by either high dose in Arm 1 or low dose in Arm 2", 
            "intervention_name": "Caffeine citrate", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Caffeine", 
                "Caffeine citrate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "high dose of caffeine", 
            "low dose of caffeine", 
            "prevention"
        ], 
        "lastchanged_date": "April 3, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Mansoura", 
                    "country": "Egypt", 
                    "state": "El Dakahlya", 
                    "zip": "35111"
                }, 
                "name": "Mansoura University Children Hospital"
            }
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "2", 
        "official_title": "High Versus Low Dose of Caffeine for Apnea of Prematurity: A Double Blind Randomized Control Trial", 
        "overall_official": [
            {
                "affiliation": "Mansoura University Children Hospital", 
                "last_name": "sameh m abbas, master", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Mansoura University Children Hospital", 
                "last_name": "nehad a nasef, MD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Egypt: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Need of re-intubation within 72 hours of extubation from mechanical ventilation", 
            "measure": "Successful extubation from mechanical ventilation", 
            "safety_issue": "No", 
            "time_frame": "72 hours after extubation from mechanical ventilation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02103777"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mansoura University Children Hospital", 
            "investigator_full_name": "Nehad Nasef", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Frequency and documented days of apnea", 
                "measure": "Apnea of prematurity", 
                "safety_issue": "No", 
                "time_frame": "Expected average of 8 weeks post natal age"
            }, 
            {
                "measure": "Duration of mechanical ventilation and oxygen support", 
                "safety_issue": "No", 
                "time_frame": "Expected 4 to 6 weeks postnatal age"
            }, 
            {
                "measure": "length of hospital stay", 
                "safety_issue": "No", 
                "time_frame": "Expected 8 weeks"
            }, 
            {
                "description": "Death before hospital discharge", 
                "measure": "Neonatal mortality", 
                "safety_issue": "No", 
                "time_frame": "Expected 8 weeks"
            }, 
            {
                "description": "Need for oxygen by 36 weeks corrected gestational age", 
                "measure": "Chronic lung disease", 
                "safety_issue": "No", 
                "time_frame": "By 36 weeks corrected gestational age"
            }, 
            {
                "measure": "Necrotising enterocolitis", 
                "safety_issue": "No", 
                "time_frame": "Expected 6 weeks"
            }, 
            {
                "measure": "Intraventricular haemorrhage", 
                "safety_issue": "No", 
                "time_frame": "Expected 2 weeks"
            }, 
            {
                "measure": "Periventricular leukomalacia", 
                "safety_issue": "No", 
                "time_frame": "Expected 8 weeks"
            }, 
            {
                "measure": "Hydrocephalus", 
                "safety_issue": "No", 
                "time_frame": "Expected 8 weeks"
            }, 
            {
                "measure": "Retinopathy of prematurity", 
                "safety_issue": "No", 
                "time_frame": "Expected 8 weeks"
            }, 
            {
                "measure": "Caffeine side effects.", 
                "safety_issue": "Yes", 
                "time_frame": "Expected 6 weeks"
            }
        ], 
        "source": "Mansoura University Children Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mansoura University Children Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}